Literature DB >> 3573154

Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity.

R G Paterson, R A Lamb, B Moss, B R Murphy.   

Abstract

To compare the relative roles of the paramyxovirus simian virus 5 (SV5) major surface glycoproteins, fusion (F) and hemagglutinin-neuraminidase (HN), in inducing protective immunity, two recombinant vaccinia viruses were constructed. The F and HN polypeptides expressed by the recombinant viruses were indistinguishable from their authentic SV5 counterparts in electrophoretic mobility, glycosylation, and, for the F protein, cleavage of the precursor, F0, to the disulfide-linked subunits F1 and F2. Injection of rabbits and hamsters with live recombinant virus elicited an antibody response to either F or HN and provided a source of monospecific polyclonal antisera to the SV5 proteins. The vaccinia virus-SV5 F (vaccinia-F) recombinant induced higher levels of neutralizing antibody than did the vaccinia-HN recombinant, but animals inoculated with vaccinia-HN were better protected from challenge with SV5. Animals infected with both the vaccinia-HN and vaccinia-F viruses were nearly as well protected from challenge as were animals infected with SV5.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3573154      PMCID: PMC254205     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  EFFECT OF ANTISERUM ON THE CELL FUSION REACTION CAUSED BY HVJ.

Authors:  Y OKADA; K YAMADA; J TADOKORO
Journal:  Virology       Date:  1964-03       Impact factor: 3.616

2.  Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution.

Authors:  M C Hsu; A Scheid; P W Choppin
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

3.  Polypeptide synthesis in simian virus 5-infected cells.

Authors:  R W Peluso; R A Lamb; P W Choppin
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

4.  The hemagglutinating and neuraminidase protein of a paramyxovirus: interaction with neuraminic acid in affinity chromatography.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

5.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

6.  Immunologic properties of purified Sendai virus glycoproteins.

Authors:  C Orvell; E Norrby
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

7.  Effect of specific antibodies on biological functions of the envelope components of Newcastle disease virus.

Authors:  J T Seto; H Becht; R Rott
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

8.  Evidence for a ninth influenza viral polypeptide.

Authors:  R A Lamb; P R Etkind; P W Choppin
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

9.  Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.

Authors:  E Norrby; G Enders-Ruckle; V Meulen
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

10.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

View more
  21 in total

1.  Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene.

Authors:  J Vialard; M Lalumière; T Vernet; D Briedis; G Alkhatib; D Henning; D Levin; C Richardson
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

2.  Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Authors:  C M Horvath; R G Paterson; M A Shaughnessy; R Wood; R A Lamb
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

Authors:  C Letellier; A Burny; G Meulemans
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.

Authors:  R Ray; B J Glaze; R W Compans
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

6.  Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein.

Authors:  K van Wyke Coelingh; E L Tierney
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  Analysis of the pH requirement for membrane fusion of different isolates of the paramyxovirus parainfluenza virus 5.

Authors:  Mei Lin Z Bissonnette; Sarah A Connolly; Daniel F Young; Richard E Randall; Reay G Paterson; Robert A Lamb
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.

Authors:  S Bagai; R A Lamb
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion.

Authors:  C M Horvath; R A Lamb
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering.

Authors:  Sarah A Connolly; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.